1894
B. V. Subba Reddy et al. / Tetrahedron Letters 52 (2011) 1891–1894
Table 2 (continued)
Entry
Anthranilamide (1)
Carbonyls (4)
Product (5)a
Time (min)
45
Yieldb (%)
82
O
O
O
NH2
NH2
NH
n
N
H
O
O
O
NH2
NH2
NH
o
40
78
N
H
a
All products were characterized by 1H NMR, IR and mass spectroscopy.
Yield refers to pure products after chromatography.
b
9. (a) Shaabani, A.; Rahmati, A.; Badri, Z. Catal. Commun. 2008, 9, 13; (b) Madhav, J.
V.; Reddy, Y. T.; Reddy, P. N.; Reddy, M. N.; Kuarm, S.; Crooks, P. A.; Rajitha, B. J.
Mol. Cat. A: Chem. 2009, 304, 85; (c) Kumar, A.; Srivastava, S.; Gupta, G.
Tetrahedron Lett. 2010, 51, 517; (d) Kumar, A.; Gupta, G.; Srivastava, S. J. Comb.
Chem. 2010, 12, 458.
10. (a) Reddy, B. V. S.; Venkateswarlu, A.; Kumar, G. G. K. S. N.; Vinu, A. Tetrahedron
Lett. 2010, 51, 6511; (b) Yadav, J. S.; Reddy, B. V. S.; Chaya, D. N.; Kumar, G. G. K.
S. N.; Naresh, P.; Jagadeesh, B. Tetrahedron Lett. 2009, 50, 1799; (c) Yadav, J. S.;
Reddy, B. V. S.; Satheesh, G. Tetrahedron Lett. 2004, 45, 3673; (d) Yadav, J. S.;
Reddy, B. V. S.; M Srinivas, M.; Prabhakar, A.; Jagadeesh, B. Tetrahedron Lett.
2004, 45, 6033; (e) Yadav, J. S.; Reddy, B. V. S.; Sunitha, V.; Reddy, K. S.;
Ramakrishna, K. V. S. Tetrahedron Lett. 2004, 45, 7947.
O
O
NH2
Cellulose-SO3H
CH3CN,rt
NH
+ RCHO
NH2
N
H
5
R
1
4
R = aryl, alkyl, naphthyl, cinnamyl, furanyl
Scheme 2. Reaction of anthranilamide with aldehydes.
11. General procedure: A mixture of carbonyl compound (1 mmol), anthranilamide
(1 mmol), and cellulose-SO3H (50 mg) in acetonitrile (5 mL) was stirred at
room temperature for a specified time (Table 1). After completion of the
reaction, as indicated by TLC, the catalyst was filtered and washed with ethyl
acetate (2 Â 10 mL) and the resulting filtrate was dried over Na2SO4 and
concentrated under vacuum. The product was purified by silica gel column
chromatography (50:50, hexane/ethyl acetate) to afford the pure 2,3-
dihydroquinazolin-4(1H)-one. The products thus obtained were characterized
by IR, NMR and mass spectroscopy. The spectral data were found to be
consistent with authentic samples.
References and notes
1. (a) Cohen, E.; Klarberg, B.; Vaughan, J. R. J. Am. Chem. Soc. 1959, 81, 5508; (b)
Yale, H. L.; Kalkstein, M. J. Med. Chem. 1967, 10, 334; (c) Okumura, K.; Oine, T.;
Yamada, Y.; Hayashi, G.; Nakama, M. J. Med. Chem. 1968, 11, 348; (d) Bonola, G.;
Da Re, P.; Massarani, E.; Magistretti, M. J.; Setnikar, I. J. Med. Chem. 1968, 11,
1136; (e) Neil, G. L.; Li, L. H.; Buskirk, H. H.; Moxlcy, T. E. Cancer Chemother.
1972, 56, 163; (f) Alaimo, R. J.; Russel, H. E. J. Med. Chem. 1972, 15, 335; (g)
Levin, J. I.; Chan, P. S.; Bailey, T.; Katocs, A. S.; Venkatesan, A. M. Bioorg. Med.
Chem. Lett. 1994, 4, 1141.
3c (Table 1): Colorless liquid, 1H NMR (300 MHz, DMSO-D6):
d 7.44 (d,
J = 6.6 Hz, 1H), 7.19 (td, J = 8.6, 11.8 Hz, 1H), 6.78 (d, J = 8.1 Hz, 1H), 6.66 (t,
J = 7.7 Hz, 1H), 4.69 (t, J = 6.2 Hz, 2H), 1.38–0.82 (m, 6H); 13C NMR (75 MHz,
DMSO-D6): d 143.7, 132.5, 128.2, 123.6, 121.2, 116.1, 115.8, 65.7, 33.3, 32.1,
20.9.; IR (KBr): mmax 3404, 2941, 2874, 1647, 1488, 1221, 1030, 769, 639; MS
(ESI): 277 [M+Na]; HRMS Calcd for C11H14N2O3Na: 277.1253. Found: 277.1248.
3e (Table 1): (2S,3R,E)-2-hydroxy-5-(4-oxo-3,4-dihydroquinazolin-2-yl)pent-
4-ene-1,3-diyl diacetate: Semi-solid, 1H NMR (300 MHz, DMSO-D6): d 7.72
(brs, 1H), 7.63 (d, J = 7.9 Hz, 1H), 7.18 (t, J = 6.7 Hz, 1H), 6.68 (t, J = 6.7 Hz, 2H),
5.89 (dd, J = 16.8, 6.2 Hz, 1H), 5.19 (d, J = 5.6 Hz, 1H), 4.16–3.76 (m, 4H) 2.30 (s,
6H); 13C NMR (75 MHz, DMSO-D6): d 170.5, 169.5, 163.6, 147.9, 133.4, 131.7,
2. (a) Maskey, R. P.; Shaaban, M.; Grun-Wollny, I.; Laatsch, H. J. Nat. Prod. 2004, 67,
1131; (b) Michael, J. P. Nat. Prod. Rep. 2004, 21, 650.
3. (a) Sugimori, T.; Okawa, T.; Eguchi, S.; Kakehi, A.; Yashima, E.; Okamoto, Y.
Tetrahedron 1998, 54, 7997; (b) Bowman, W. R.; Elsegood, M. R. J.; Stein, T.;
Weaver, G. W. Org. Biomol. Chem. 2007, 5, 103; (c) Kshirsagar, U. A.; Argade, N.
P. Org. Lett. 2010, 12, 3716; (d) Ma, Z. Z.; Hano, Y.; Nomura, T.; Chen, Y. J. Bioorg.
Med. Chem. Lett. 2004, 14, 1193.
4. (a) Witt, A.; Bergman, J. Curr. Org. Chem. 2003, 7, 659. and references cited
therein; (b)Mhaske, S. B.;Argade, N. P. Tetrahedron 2006, 62, 9787. and references
cited therein; (c) Larksarp, C.; Alper, H. J. Org. Chem. 2000, 65, 2773; (d)
Sadanandam, Y. S.; Reddy, K. R. M.; Rao, A. B. Eur. J. Org. Chem. 1987, 22, 169; (e)
Kalusa, A.; Chessum, N.;Jones, K. Tetrahedron Lett. 2008, 49, 5840; (f)Xia, Y.; Yang,
Z. Y.; Hour, M. J.; Kuo, S. C.; Xia, P.; Bastow, K. F.; Nakanishi, Y.; Nampoothiri, P.;
Hackl, T.; Hamel, E.; Lee, K. H. Bioorg. Med. Chem. Lett. 2001, 11, 1193; (g) Liu, X.
W.; Fu, H.; Jiang, Y. Y.; Zhao, Y. F. Angew. Chem., Int. Ed. 2009, 48, 348.
5. (a) Zhang, Z.-H.; Lu, H.-Y.; Yang, S.-H.; Gao, J.-W. J. Comb. Chem. 2010, 12, 643;
(b) Moore, J. A.; Sutherland, G. J.; Sowerby, R.; Kelly, E. G.; Palermo, S.; Webster,
W. J. Org. Chem. 1969, 34, 887; (c) Mannschreck, A.; Koller, H.; Stuhler, G.;
Davies, M. A.; Traber, J. E. J. Med. Chem. 1994, 19, 381; (d) Corbett, J. W.; Ko, S. S.;
Rodgers, J. D.; Gearhart, L. A.; Magnus, N. A.; Bachheler, L. T.; Diamond, S.;
Jeffey, S.; Trainor, G. L.; Anderson, P. S.; Erickson-Vitanen, K. J. Med. Chem. 2000,
43, 2019; (e) Liu, J. F.; Lee, J.; Dalton, A. M.; Bi, G.; Yu, L.; Baldino, C. M.; McElory,
E.; Brown, M. Tetrahedron Lett. 2005, 46, 1241.
6. (a) Hour, M. J.; Huang, L. J.; Kuo, S. C.; Xia, Y.; Bastow, K.; Nakanishi, Y.; Hamel,
E.; Lee, K. H. J. Med. Chem. 2000, 43, 4479; (b) Shi, D. Q.; Rong, L. C.; Wang, J. X.;
Zhuang, Q. Y.; Wang, X. S.; Hu, H. W. Tetrahedron Lett. 2003, 44, 3199; (c) Abdel-
Jalil, R. J.; Voelter, W.; Saeed, M. Tetrahedron Lett. 2004, 45, 3475; (d) Chen, J.;
Su, W.; Wu, H.; Liub, M.; Jin, C. Green Chem. 2007, 9, 972;; (e) Chinigo, G. M.;
Paige, M.; Grindrod, S.; Hamel, E.; Dakshanamurthy, S.; Chruszcz, M.; Minor,
W.; Milton, L.; Brown, M. L. J. Med. Chem. 2008, 51, 4620; (f) Shaabani, A.; Ali
Maleki, A.; Mofakham, H. Synth. Commun.1 2008, 38, 3751.
128.7, 127.3, 114.4, 73.7, 69.3, 67.5, 20.9, 20.7.; IR(KBr):
1650, 1490, 1254, 1034, 760; MS (ESI): 347 [M+H]; HRMS Calcd for
17H19N2O6: 347.1243. Found: 347.1248.
mmax 3432, 3084, 2919,
C
5a (Table 2): 2-(4-Methoxyphenyl)-2,3-dihydroquinazolin-4(1H)-one: White
solid, m.p. 189–191 °C, 1H NMR (300 MHz, CDCl3+DMSO, 3:1): d 7.78 (brs, 1H),
7.64 (dd, J = 7.7 Hz, 1H), 7.43 (d, J = 8.6 Hz, 2H) 7.18 (t, J = 8.1 Hz, 1H), 6.88 (d,
J = 8.4 Hz, 2H), 6.63–6.73 (m, 2H), 5.71 (s, 1H), 3.78 (s, 3H) 13C NMR (75 MHz,
CDCl3+DMSO): d 163.9, 159.9, 147.3, 132.7, 127.7, 127.0, 117.2, 113.8, 113.0,
67.0, 54.4; IR (KBr): mmax 3443, 2924, 2853, 1656, 1612, 1511, 1385, 1247, 757;
MS (ESI): 255 [M+H]; HRMS Calcd for C15H15N2O2: 255.1133. Found: 255.1134.
5c (Table 2): 2-(3-Phenoxyphenyl)-2,3-dihydroquinazolin-4(1H)-one: Semi-
solid, 1H NMR (300 MHz, CDCl3+DMSO, 3:1):
d 7.87 (brs, 1H), 7.66 (dd,
J = 7.7 Hz, 1H), 7.16–7.35 (m, 6H), 7.08 (t, J = 7.6 Hz, 1H), 6.96 (d, J = 8.5 Hz, 2H),
6.91 (brs, 1H), 6.63–6.73 (m, 3H), 5.74 (s, 1H); 13C NMR (75 MHz,
CDCl3+DMSO): d 161.9, 154.8, 154.5, 145.8, 141.9, 131.4, 128.0, 125.5, 121.5,
119.9, 116.7, 115.4, 115.2, 112.6, 64.4; IR (KBr): mmax 3423, 3084, 2929, 2857,
1662, 1485, 1338, 1023, 764; MS (ESI): 317 [M+H]; HRMS Calcd for
C
20H17N2O2: 317.1290. Found: 317.1297.
5e (Table 2): 2-(Furan-2-yl)-2,3-dihydroquinazolin-4(1H)-one: Light yellow
solid, m.p. 120–121 °C: 1H NMR (300 MHz, CDCl3+DMSO, 3:1): d 8.06 (d,
J = 2.5 Hz, 1H), 7.71 (brs, 1H), 7.67 (dd, J = 7.7 Hz, 1H), 7.19 (t, J = 8.3 Hz, 1H),
6.70 (t, J = 8.1 Hz, 2H), 6.65 (brs, 1H), 6.29 (s, 2H), 5.75 (d, J = 3.2 Hz, 1H); 13C
NMR (75 MHz, CDCl3+DMSO): d 163.9, 152.8, 146.3, 142.0, 141.9, 133.0, 127.3,
117.8, 114.3, 109.7, 107.1, 60.8; IR (KBr): mmax 3416, 3259, 3034, 2921, 1650,
1611, 1467, 1386, 732; MS (ESI): 215 [M+H]; HRMS Calcd for C12H11N2O2:
215.0820. Found: 215.0830.
7. (a) Cheng, X.; Vellalath, S.; Goddard, R.; List, B. J. Am. Chem. Soc. 2008, 130,
15786; (b) Rueping, M.; Antonchick, A. P.; Sugiono, E.; Grenader, K. Angew.
Chem. Int. Ed. 2009, 48, 908.
8. (a) Kozhevnikov, I. V. Chem. Rev. 1998, 98, 171; (b) Paolis, O. D.; Teixeira, L.;
Török, B. Tetrahedron Lett. 2009, 50, 2939; (c) Niknam, K.; Saberi, D.; Sefat, M. N.
Tetrahedron Lett. 2010, 51, 2959.
12. The catalyst, cellulose-sulfonic acid, was prepared according to the literature
procedure: Shaabani, A.; Maleki, A. Applied Catalysis A: General 2007, 331, 149.